Herbas, John Michael M.
HRN: 24-66-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
03/08/2024
03/11/2024
ORAL
7mL
BID
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes